These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 23681165)

  • 21. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability.
    Lapiz MD; Morilak DA
    Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats.
    Eagle DM; Wong JC; Allan ME; Mar AC; Theobald DE; Robbins TW
    J Neurosci; 2011 May; 31(20):7349-56. PubMed ID: 21593319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.
    Liu YP; Huang TS; Tung CS; Lin CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():81-90. PubMed ID: 25151304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
    Bari A; Eagle DM; Mar AC; Robinson ES; Robbins TW
    Psychopharmacology (Berl); 2009 Aug; 205(2):273-83. PubMed ID: 19404616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
    Dela Peña I; Shen G; Shi WX
    Eur J Pharmacol; 2021 Feb; 892():173826. PubMed ID: 33347825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell VA
    Behav Brain Res; 2002 Mar; 130(1-2):191-6. PubMed ID: 11864734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
    Arnsten AF
    CNS Drugs; 2009; 23 Suppl 1():33-41. PubMed ID: 19621976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.
    Sigala S; Rizzonelli P; Zanelli E; Forgione A; Missale C; Spano P
    Eur J Pharmacol; 1991 Jun; 199(2):247-53. PubMed ID: 1683290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline-dependent effects of cocaine pre-exposure on impulsivity and D2/3 receptor availability in the rat striatum: possible relevance to the attention-deficit hyperactivity syndrome.
    Caprioli D; Hong YT; Sawiak SJ; Ferrari V; Williamson DJ; Jupp B; Adrian Carpenter T; Aigbirhio FI; Everitt BJ; Robbins TW; Fryer TD; Dalley JW
    Neuropsychopharmacology; 2013 Jul; 38(8):1460-71. PubMed ID: 23399948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride.
    Pezze MA; Dalley JW; Robbins TW
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):307-13. PubMed ID: 18985321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids/glucocorticoid receptors effect on dopaminergic neurotransmitters in ADHD rats.
    Chen Y; Zheng X; Xie L; Huang L; Ke Z; Zheng J; Lu H; Hu J
    Brain Res Bull; 2017 May; 131():214-220. PubMed ID: 28458039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task.
    Pezze MA; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2007 Feb; 32(2):273-83. PubMed ID: 16641946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    J Neurochem; 2004 Feb; 88(4):1003-9. PubMed ID: 14756822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.
    Agnoli L; Carli M
    Psychopharmacology (Berl); 2012 Jan; 219(2):633-45. PubMed ID: 22113450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat.
    Milstein JA; Lehmann O; Theobald DE; Dalley JW; Robbins TW
    Psychopharmacology (Berl); 2007 Jan; 190(1):51-63. PubMed ID: 17096085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D2/3 Receptor Availabilities and Evoked Dopamine Release in Striatum Differentially Predict Impulsivity and Novelty Preference in Roman High- and Low-Avoidance Rats.
    Bellés L; Dimiziani A; Tsartsalis S; Millet P; Herrmann FR; Ginovart N
    Int J Neuropsychopharmacol; 2021 Mar; 24(3):239-251. PubMed ID: 33151278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Milnacipran enhances the control of impulsive action by activating D₁-like receptors in the infralimbic cortex.
    Tsutsui-Kimura I; Ohmura Y; Izumi T; Kumamoto H; Yamaguchi T; Yoshida T; Yoshioka M
    Psychopharmacology (Berl); 2013 Jan; 225(2):495-504. PubMed ID: 22892727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.